Abstract
In the above article [Ayyar VS, DuBois DC, Nakamura T, Almon RR, and Jusko WJ (2019) J Pharmacol Exp Ther, 370(2): 327-336; DOI: https://doi.org/10.1124/jpet.119.257527], the following funding information was omitted: This work was supported by the National Institutes of Health National Institute of General Medical Sciences [Grants GM24211 and GM131800]. The HTML and PDF versions of the article have been updated to include this information. The authors regret this error and any inconvenience it may have caused.
| Original language | English |
|---|---|
| Pages (from-to) | 436 |
| Number of pages | 1 |
| Journal | Journal of Pharmacology and Experimental Therapeutics |
| Volume | 370 |
| Issue number | 3 |
| DOIs |
|
| State | Published - 2019 |
Fingerprint
Dive into the research topics of 'Correction: Modeling corticosteroid pharmacokinetics and pharmacodynamics, Part II: Sex differences in methylprednisolone pharmacokinetics and corticosterone suppression (Journal of Pharmacology and Experimental Therapeutics (2019) 370: 2 (327-336) DOI: 10.1124/jpet.119.257527)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver